??-Adrenoceptor Antagonists in the Treatment of Benign Prostatic Hyperplasia
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 57 (1) , 9-17
- https://doi.org/10.2165/00003495-199957010-00002
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Long‐term treatment of benign prostatic hyperplasia with alfuzosin: a 24–30 month surveyBritish Journal of Urology, 1994
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBritish Journal of Urology, 1994
- Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study GroupArchives of Family Medicine, 1993
- Doxazosin Treatment in Patients with Prostatic ObstructionScandinavian Journal of Urology and Nephrology, 1993
- TerazosinDrugs & Aging, 1993
- A 12‐Week Placebo‐controlled Double‐blind Study of Prazosin in the Treatment of Prostatic Obstruction due to Benign Prostatic HyperplasiaBritish Journal of Urology, 1992
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- Bladder Outflow Obstruction Treated with PhenoxybenzamineBritish Journal of Urology, 1982
- Alpha-adrenergic blockers in prostatismBritish Journal of Surgery, 1977